Corrigendum: The effects of pemafibrate and Omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)

• Yasutaka Takeda,
• Ichiro Sakuma,
• Shinya Hiramitsu,
• Mizuho Okada,
• Shinichiro Ueda,
• Masaru Sakurai

Affiliations

Yasutaka Takeda

Division of Metabolism and Biosystemic Science, Gastroenterology, and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan

Ichiro Sakuma

Caress Sapporo Hokko Memorial Clinic, Sapporo, Japan

Shinya Hiramitsu

Hiramitsu Heart Clinic, Nagoya, Japan

Mizuho Okada

Keiyukai Yoshida Hospital, Asahikawa, Japan

Shinichiro Ueda

Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus, Nishihara, Japan

Masaru Sakurai

Department of Social and Environmental Medicine, Kanazawa Medical University, Uchinada, Japan